ReGen5

ReGen5 is a human amniotic fluid-derived biological product developed by Regenative Labs, primarily intended for use in regenerative medicine applications such as the treatment of orthopedic injuries, joint pain, and various inflammatory conditions. As an amniotic fluid allograft, it consists of a complex mixture of biologically active components, including growth factors (such as transforming growth factor-beta, epidermal growth factor, and fibroblast growth factor), cytokines, hyaluronic acid, and extracellular matrix proteins. The mechanism of action involves providing a biological scaffold and a concentrated signaling environment that facilitates tissue repair, modulates the inflammatory response, and supports the body's endogenous healing processes. While marketed for various clinical uses, the FDA has classified products like ReGen5 as biological drugs that require a Biologics License Application (BLA) for lawful marketing for specific therapeutic indications, as they are considered to be more than minimally manipulated or intended for non-homologous use.

Brand names

ReGen5ReGen-5ReGen 5

Other names

Human Amniotic FluidAmniotic Fluid Allograft